Inspiratory capacity predicts mortality in patients with chronic obstructive pulmonary disease
Authors:
- C. TantucciCTC. Tantucci
- P. DonatiPDP. Donati
- F. NicosiaFNF. Nicosia
- E. BertellaEBE. Bertella
- S. RedolfiSRS. Redolfi
- M. De VecchiMVM. De Vecchi
- L. CordaLCL. Corda
- V. GrassiVGV. Grassi
- R. ZulliRZR. Zulli
- 1 April 2008
- journal article
- Published by Elsevier in Respiratory Medicine
- Vol. 102 (4) , 613-619
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Reference values and repeatability of inspiratory capacity for men and women aged 65–85Respiratory Medicine, 2006
- Flow limitation and dynamic hyperinflation: key concepts in modern respiratory physiologyEuropean Respiratory Journal, 2005
- Health outcomes following treatment for six months with once daily tiotropium compared with twice daily salmeterol in patients with COPDThorax, 2003
- Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trialThe Lancet, 2003
- Exercise Hypercapnia in Advanced Chronic Obstructive Pulmonary Disease: The Role of Lung HyperinflationAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Dynamic Hyperinflation and Exercise Intolerance in Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2001
- Variables related to increased mortality following out-patient pulmonary rehabilitationEuropean Respiratory Journal, 1996
- A simple method to detect expiratory flow limitation during spontaneous breathingEuropean Respiratory Journal, 1995
- Exertional Breathlessness in Patients with Chronic Airflow Limitation: The Role of Lung HyperinflationAmerican Review of Respiratory Disease, 1993
- Lung Function Testing: Selection of Reference Values and Interpretative StrategiesAmerican Review of Respiratory Disease, 1991